Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib.

Wong, Han Hsi; Bentley, Helen; Bulusu, Venkata Ramesh; Anyaegbu, Gloria; Watkins, James; Horan, Gail; Hatcher, Helen

Wong, Han Hsi; Bentley, Helen; Bulusu, Venkata Ramesh; Anyaegbu, Gloria; Watkins, James; Horan, Gail; Hatcher, Helen.

Affiliation

Wong HH; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.

Anticancer Drugs ; 31(10): 1106-1110, 2020 11.

Article in En | MEDLINE | ID: mdl-32868646

Subject(s)

Benzamides/therapeutic use; Granuloma, Plasma Cell/drug therapy; Indazoles/therapeutic use; Lactams, Macrocyclic/therapeutic use; Lung Neoplasms/drug therapy; Adult; Aminopyridines; Anaplastic Lymphoma Kinase/antagonists & inhibitors; Anaplastic Lymphoma Kinase/genetics; Gene Fusion; Granuloma, Plasma Cell/diagnostic imaging; Granuloma, Plasma Cell/genetics; Granuloma, Plasma Cell/pathology; Humans; Inflammation/drug therapy; Inflammation/pathology; Lactams; Lung Neoplasms/diagnostic imaging; Lung Neoplasms/genetics; Lung Neoplasms/pathology; Male; Protein Kinase Inhibitors/therapeutic use; Pyrazoles; Treatment Failure; Tropomyosin/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Benzamides / Lactams, Macrocyclic / Granuloma, Plasma Cell / Indazoles / Lung Neoplasms Limits: Adult / Humans / Male Language: En Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google